Vol. 12.Issue. 1. January - February 2013 | Annals of Hepatology

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Buscar en

Annals of Hepatology

Toda la web

Inicio Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2022

3.8

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2022

6.3

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2022

0.859

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2022

0.989

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 12. Issue 1.

Pages 4-165 (January - February 2013)

Hepatology highlights

Hepatology Highlights

Kevork M. Peltekian

Ann Hepatol. 2013;12:4-5

Open access

Concise review

Use of acetylcysteine for non-acetaminophen-induced acute liver failure

Ibrahim Sales, Amy L. Dzierba, Pamela L. Smithburger, Deanna Rowe, Sandra L. Kane-Gill

Ann Hepatol. 2013;12:6-10

Open access

Herbal hepatotoxicity and WHO global introspection method

Rolf Teschke, Axel Eickhoff, Albrecht Wolff, Christian Frenzel, Johannes Schulze

Ann Hepatol. 2013;12:11-21

Open access

Hepatic venous pressure gradient measurement in pre-primary and primary prophylaxis of variceal hemorrhage

Julio D. Vorobioff, Roberto J Groszmann

Ann Hepatol. 2013;12:22-9

Open access

Original article

Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4

Juan José Urquijo, Moisés Diago, Jaume Boadas, Ramón Planas, Ricard Solá, Juan Angel del Olmo, Javier Crespo, José Carlos Erdozaín, ... Miguel Montoro

Ann Hepatol. 2013;12:30-5

Open access

Long-term follow-up of hepatitis C virus-positive patients with persistently normal serum transaminases

Emanuele La Spada, Maurizio Soresi, Lydia Giannitrapani, Monica La Spada, Elisa Campagna, Antonino Terranova, Fabio Cartabellotta, Giuseppe Montalto

Ann Hepatol. 2013;12:36-43

Open access

Diagnostic value of fibronectin discriminant score for predicting liver fibrosis stages in chronic hepatitis C virus patients

Abdelfattah M. Attallah, Sanaa O. Abdallah, Ahmed A. Attallah, Mohamed M. Omran, Khaled Farid, Wesam A. Nasif, Gamal E. Shiha, Abdel-Aziz F. Abdel-Aziz, ... Yehia M. Shaker

Ann Hepatol. 2013;12:44-53

Open access

Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation

Mohsen S. Elalfy, Gamal Esmat, Randa M. Matter, Hesham E. Abdel Aziz, Walid A. Massoud

Ann Hepatol. 2013;12:54-61

Open access

Patients younger than forty years old with hepatitis C virus genotype–1 chronic infection had treatment responses similar to genotype–2 infection and not related to interleukin–28B polymorphism

Chun-Yen Lin, I-Shyan Sheen, Wen-Juei Jeng, Chang-Wen Huang, Chien-Hao Huang, Ji-Yih Chen

Ann Hepatol. 2013;12:62-9

Open access

Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study

Ignazio Grattagliano, Enzo Ubaldi, Luigi Napoli, Carlo Fedele Marulli, Cristina Nebiacolombo, Carmelo Cottone, Piero Portincasa

Ann Hepatol. 2013;12:70-7

Open access

Hepatitis C virus infection in patients with primary biliary cirrhosis

Hsuan-Wei Chen, Hsin-Hung Huang, Ching-Huang Lai, Wei-En Chang, Yu-Lueng Shih, Wei-Kuo Chang, Tsai-Yuan Hsieh, Heng-Cheng Chu

Ann Hepatol. 2013;12:78-84

Open access

Impact of the severity of end-stage liver disease in cardiac structure and function

Odilson Marcos Silvestre, Fernando Bacal, Danusa de Souza Ramos, Jose L. Andrade, Meive Furtado, Vincenzo Pugliese, Elisangela Belleti, Wellington Andraus, ... Alberto Queiroz Farias

Ann Hepatol. 2013;12:85-91

Open access

High age and low sodium urine concentration are associated with poor survival in patients with hepatorenal syndrome

Matthias Hinz, Alexander Wree, Christoph Jochum, Lars P. Bechmann, Fuat Saner, Alexander L. Gerbes, Guido Gerken, A.l.i. Canbay

Ann Hepatol. 2013;12:92-9

Open access

Feasibility and reliability of the FibroScan S2 (pediatric) probe compared with the M probe for liver stiffness measurement in small adults with chronic liver disease

Faruq Pradhan, Farah Ladak, Jenna Tracey, Pam Crotty, Robert P. Myers

Ann Hepatol. 2013;12:100-7

Open access

How to diagnose hepatic encephalopathy in the emergency department

Felix Gundling, Edin Zelihic, Holger Seidl, Bernhard Haller, Andreas Umgelter, Wolfgang Schepp, Christoph Dodt

Ann Hepatol. 2013;12:108-14

Open access

Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat

Yi-Sun Song, Cheng-Hu Fang, Byung-Im So, Jun-Young Park, Dae Won Jun, Kyung-Soo Kim

Ann Hepatol. 2013;12:115-22

Open access

Spondias pinnata stem bark extract lessens iron overloaded liver toxicity due to hemosiderosis in Swiss albino mice

Bibhabasu Hazra, Rhitajit Sarkar, Nripendranath Mandal

Ann Hepatol. 2013;12:123-9

Open access

Evidence that estrogen receptors play a limited role in mediating enhanced recovery of bile flow in female rats in the acute phase of liver ischemia reperfusion injury

Heleen A.H. de Vries, Fraukje A.M. Ponds, Vincent B. Nieuwenhuijs, Arthur Morphett, Robert T.A. Padbury, Greg J. Barritt

Ann Hepatol. 2013;12:130-7

Open access

Images in hepatology

Granulomatous hepatitis caused by Q fever: a differential diagnosis of fever of unknown origin

Nancy Aguilar-Olivos, María del Carmen Manzano-Robleda, Ylse Gutiérrez-Grobe, Fredy Chablé-Montero, Jorge Albores-Saavedra, Eric López-Méndez

Ann Hepatol. 2013;12:138-41

Open access

Case report

Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: A closer look at the role of siderosis

Joseph E. Maakaron, Maria Domenica Cappellini, Giovanna Graziadei, Jad Bou Ayache, Ali T. Taher

Ann Hepatol. 2013;12:142-6

Open access

Autoimmune hepatitis type-2 and Epstein-Barr virus infection in a toddler: art of facts or an artifact?

Aglaia Zellos, Vana Spoulou, Eleftheria Roma-Giannikou, Ourania Karentzou, George N. Dalekos, Maria Theodoridou

Ann Hepatol. 2013;12:147-51

Open access

Severe hepatitis induced by cyproterone acetate: role of corticosteroids. A case report

Ludovico Abenavoli, Natasa Milic, Michel Beaugrand

Ann Hepatol. 2013;12:152-5

Open access

First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder

Nawal Al Nahdi, Jo-Ann Ford, Erica D. Greanya, Jo-Ann Harrigan, Irene Tse, Urs P. Steinbrecher, Siegfried R. Erb, Eric M. Yoshida

Ann Hepatol. 2013;12:156-60

Open access

Letter to editor

Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease

Pietro Vajro, Claudia Mandato, Claudio Veropalumbo, Ida De Micco

Ann Hepatol. 2013;12:161-3

Open access

Liver news elsewhere

Raloxifene hydrochloride as hepatitis C treatment

Miguel Motola-Kuba, Nahum Méndez-Sánchez

Ann Hepatol. 2013;12:164-5

Open access